INOVIO Prices $20M Offering at $0.95, Deepening Dilution Fears
INO is trading near its 52-week low of $0.95 (14% below the low).
Summary
INOVIO priced its public offering at $0.95 per share, raising $20 million through 21.05 million shares and warrants. The price is a modest premium to the $0.8195 market close, but the offering is highly dilutive—adding roughly 25% to the outstanding share count. This follows the July 29 announcement of the offering and the July 2 $300 million shelf registration, underscoring the company's urgent need for cash with only $36.7 million on hand at Q2 end. The deep discount to the 52-week high of $2.98 reflects severe market skepticism about INOVIO's pipeline and liquidity. The capital infusion extends the runway but at a steep cost to existing shareholders. The offering is expected to close around July 31.
At the time of this announcement, INO was trading at $0.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $85.6M. The 52-week trading range was $0.95 to $2.98. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.